Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.24486 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.17919 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.18206 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.0719 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.10017 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.36919 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.2937 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.23793 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.16363 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.15019 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17763 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16584 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.18044 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.18195 | 50 |